Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Urology. 2009 Nov 14;75(4):779–785. doi: 10.1016/j.urology.2009.08.063

Table 2.

Risk of prostate cancer in relation to SNPs in genes involved in oxidative DNA repair in a population-based case-control study of prostate cancer in Arkansas, 1998–2003

Cases (n=193)
Controls (n=197)
Genotype Number % Number % OR (95% CI)a P value
hOGG1 (Ser326Cys)
 Ser/Ser 126 66.0 118 60.2 1.00b
 Ser/Cys or Cys/Cys 65 34.0 78 39.8 0.72 (0.46, 1.10) 0.13
 Allele frequency of Cys 18.1 21.7
XRCC1 (Arg399Gln)
 Arg/Arg 102 53.7 127 65.1 1.00b
 Arg/Gln or Gln/Gln 88 46.3 68 34.9 1.56 (1.01, 2.45) 0.049
 Allele frequency of Gln 26.8 18.2

Ser, Serine; Cys, Cytosine; Arg, Arginine; Gln, Glutamine.

a

Adjusted for age, race, body mass index, education, and smoking status.

b

Reference.